Log in to search using one of your social media accounts:

 

10 Facts Women Should Know About Endometrial Cancer
The most common cancer of the reproductive organs in American women is endometrial cancer. The American Cancer Society estimates that for the year 2017, around 61,380 new cases of cancer of the body of the uterus will be diagnosed and about 10,920 women will die from cancers of the uterine body. These figures include both endometrial cancers and uterine sarcomas. Since endometrial cancer is a fairly common cancer in women, the more women know the facts about this disease, the greater their chance of knowing what symptoms to be aware of in order to have it diagnosed as early as possible, improving the likelihood of surviva...
Source: Healthy Living - The Huffington Post - June 5, 2017 Category: Consumer Health News Source Type: news

Uterine Sarcomas: The Latest Approaches for These Rare but Potentially Deadly Tumors
In this review we discuss preoperative diagnosis and the role of pathology, and we summarize the current literature regarding the management of uterine sarcomas. (Source: CancerNetwork)
Source: CancerNetwork - March 15, 2017 Category: Cancer & Oncology Authors: Jing-Yi Chern, MD, ScM Leslie R. Boyd, MD Stephanie V. Blank, MD Tags: Gynecologic Cancers Oncology Journal Review Article Sarcoma Source Type: news

PI3K/mTOR inhibitors may be effective against some uterine sarcomas
The protein P-S6S240 may serve as an indicator of poor prognosis for patients with a hard-to-treat type of uterine sarcoma called leiomyosarcoma, and preclinical data suggest that patients whose tumors have this protein may respond to PI3K/mTOR inhibitors. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 23, 2017 Category: Science Source Type: news

PI3K/mTOR inhibitors may be effective against some uterine sarcomas
(American Association for Cancer Research) The protein P-S6S240 may serve as an indicator of poor prognosis for patients with a hard-to-treat type of uterine sarcoma called leiomyosarcoma, and preclinical data suggest that patients whose tumors have this protein may respond to PI3K/mTOR inhibitors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 23, 2017 Category: Cancer & Oncology Source Type: news

GAO flags gaps in FDA ’ s adverse event system in power morcellator report
Limitations in the FDA’s adverse event reporting system for medical devices helped allow the widespread use of laparoscopic power morcellators for years before the risk that they can spread cancer became known, a government watchdog said this week. Medical device manufacturers and importers are required to tell the FDA about any device-related adverse events within 30 days. “FDA officials noted, however, the limitations in the current, passive, medical device reporting system, which relies on people to identify that a harm occurred or a risk is present, recognize that the harm or risk is associat...
Source: Mass Device - February 10, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Wall Street Beat Women's Health Capitol Hill U.S. Government Accountability Office (GAO) Source Type: news

Gwen Ifill's Death Shows We Need Better Endometrial Cancer Research
Venerated journalist and anchor Gwen Ifill died Monday at the age of 61. The cause of death was endometrial cancer, with which she was diagnosed less than a year ago.  Endometrial cancer has a reputation for being one of the most treatable and least-lethal gynecological cancers that women face. But as Ifill’s case shows, a significant minority of cases can be aggressive and fast-paced ― and they’re more likely to be concentrated among black women. For women who have recurrent endometrial cancer, doctors have few medications that can specifically target growth.  “We don’t have as many too...
Source: Science - The Huffington Post - November 16, 2016 Category: Science Source Type: news

Olympus wins FDA nod & launches new power morcellator with tissue capture
Olympus (TYO:7733) said today it won FDA 510(k) clearance for its next-gen laparoscopic PK morcellator with tissue containment designed as a laparoscopic surgery option to avoid open hysterectomy and myomectomy for uterine fibroid removal The company’s newly launched morcellator includes the company’s PneumoLiner contained tissue extraction system. “Contained tissue extraction is continually evolving. As surgeons, it is our duty to evaluate potential solutions to the surgical challenges we face in clinical practice. We are pleased that Olympus has taken the initiative to develop a unique and well tes...
Source: Mass Device - November 16, 2016 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Business/Financial News Food & Drug Administration (FDA) Regulatory/Compliance Women's Health Olympus Source Type: news

Power morcellation rates plunged after FDA warnings
Use of electric power morcellation for hysterectomy procedures has significantly declined after the FDA warned against the use of such devices in 2014, according to a new study. Data from the study was published this month in the Journal of the American Medical Association. The study examined a total of 203,520 women who underwent hysterectomy procedures from 2013 to the 1st quarter of 2015 as recorded in the Perspective database, which includes more than 500 hospitals in the U.S. Researchers found that the use of power morcellators peaked in the 4th quarter of 2013 at 13.7%, and dropped to only 2.8% by the 1st quarter of ...
Source: Mass Device - August 23, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Food & Drug Administration (FDA) Women's Health Source Type: news

ACS Report: Number of US Cancer Survivors Expected to Exceed 20 Million by 2026
By Stacy Simon A new report by the American Cancer Society – in collaboration with the National Cancer Institute – estimates there are more than 15.5 million cancer survivors alive in the US today, and that number will grow to more than 20 million by 2026. This includes everyone who’s ever had cancer, from the time of diagnosis for the rest of their life. The report, “Cancer Treatment & Survivorship Facts & Figures 2016-2017,” and an accompanying journal article in CA: A Cancer Journal for Clinicians were released June 2, 2016. The report says even though the rates of new cancer cases ...
Source: American Cancer Society :: News and Features - June 2, 2016 Category: Cancer & Oncology Tags: Coping with Cancer Breast Cancer Prostate Cancer Colon/Rectum Cancer Skin Cancer - Melanoma Source Type: news

Johnson & Johnson looks to settle morcellator lawsuits
Johnson & Johnson(NYSE:JNJ) is reportedly looking to settle 100s of product liability and wrongful death lawsuits brought over its now-recalled laparoscopic power morcellators used during surgeries to remove ostensibly benign uterine tumors. The morcellators, which use a cutting tip to shred and remove uterine tissue, have been implicated in the spread of a lethal cancer that can masquerade undetected as benign fibroids. The FDA in April 2014 issued a warning about the devices, later convening a special advisory panel to evaluate their continued use in the surgical suite. The watchdog agency estimat...
Source: Mass Device - March 21, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Legal News Product Liability Surgical Ethicon Inc. Johnson & Johnson Source Type: news

Report: Feds to investigate power morcellators
The Government Accountability Office said last week it will investigate potential safety and regulatory issues with laproscopic power morcellators, according to The Wall Street Journal. The devices use small, rotating blades to break up large tissue masses into fragments, and are commonly used to remove uterine fibroids in women. However, if the device is used on a patient with an undetected cancerous growth, it can enable the cancer to spread, according to the FDA. The tools have been under the scrutiny of the FDA for over a year – last November, the agency released a security communication warning that women underg...
Source: Mass Device - September 11, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Food & Drug Administration (FDA) Gynecological Regulatory/Compliance Women's Health U.S. Government Accountability Office (GAO) Source Type: news

Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on...
The decision by UnitedHealthCare to restrict laparoscopic or abdominal hysterectomies comes months after the FDA warned against the use of power morcellators in such procedures, as the devices may...(PRWeb March 02, 2015)Read the full story at http://www.prweb.com/releases/power-morcellator-lawsuit/uterine-sarcoma-cancer/prweb12553772.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 3, 2015 Category: Pharmaceuticals Source Type: news

Risk of unexpected sarcoma being discovered after hysterectomy appears fairly low
Uterine sarcoma -- a potentially aggressive type of cancer that forms in tissues in the uterus -- was found in 0.22 % of women following a hysterectomy for benign conditions, a new large-scale study shows. Authors say findings may have implications for the risks associated with morcellation. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 19, 2015 Category: Science Source Type: news

Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on...
Morcellator lawsuits filed on behalf of women who allegedly experienced the spread of uterine sarcoma and other malignancies have been mounting in U.S. courts following warnings from the FDA about the...(PRWeb February 12, 2015)Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/morcellator-cancer/prweb12514418.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 14, 2015 Category: Pharmaceuticals Source Type: news

Low Uterine Sarcoma Rates Among Women Undergoing Leiomyomata SurgeryLow Uterine Sarcoma Rates Among Women Undergoing Leiomyomata Surgery
Uterine sarcoma rates are quite low among women undergoing surgery for uterine leiomyomata, especially women younger than 50 years, researchers report. Reuters Health Information (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - February 12, 2015 Category: OBGYN Tags: Ob/Gyn & Women ' s Health News Source Type: news

Power Morcellation Associated With 0.6% Cancer IncidencePower Morcellation Associated With 0.6% Cancer Incidence
A new study has calculated the percentage of women who undergo laparoscopic hysterectomy with power morcellation and are later diagnosed with uterine sarcomas or parasitic myomas. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 26, 2014 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Concerns Over Power Morcellators Mount, as Bernstein Liebhard LLP...
The publication of this latest power morcellator study follows warnings from U.S. health regulators regarding the potential for uterine morcellation to spread undetected uterine sarcomas and other...(PRWeb December 23, 2014)Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/morcellator-cancer/prweb12413988.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 23, 2014 Category: Pharmaceuticals Source Type: news

Power Morcellator Cancer Risk Prompts Canadian Regulators to Issue...
The warning comes as women in the U.S. pursue morcellator lawsuits after allegedly experiencing the spread of uterine sarcoma and other cancers due to uterine morcellation.(PRWeb December 16, 2014)Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/morcellator-cancer/prweb12399400.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 18, 2014 Category: Pharmaceuticals Source Type: news

Power Morcellator Cancer Risk Confirmed by FDA, As Bernstein Liebhard...
The FDA's new morcelltor cancer warning comes amid growing concerns that uterine morcellation may have caused numerous women to experience the spread of uterine sarcoma, leiomyosarcoma and other...(PRWeb November 25, 2014)Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/morcellator-cancer/prweb12355345.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 26, 2014 Category: Pharmaceuticals Source Type: news

Power Morcellator News: Bernstein Liebhard LLP Notes Uncle’s Plea to...
The Firm is evaluating potential morcellator lawsuits on behalf of woman who allegedly experienced the spread of gynecological cancers, including uterine sarcoma and leiomyosarcoma, following uterine...(PRWeb November 17, 2014)Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/morcellator-cancer/prweb12332279.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 18, 2014 Category: Pharmaceuticals Source Type: news

As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Notes...
The Firm is evaluating potential morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine sarcoma, other cancers due to uterine morcellation.(PRWeb November 13, 2014)Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/morcellator-cancer/prweb12325335.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 13, 2014 Category: Pharmaceuticals Source Type: news

Power Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Report...
The Firm is evaluating morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine sarcomas and other cancers due to the use of power morcellators in laparoscopic...(PRWeb November 06, 2014)Read the full story at http://www.prweb.com/releases/power-morcellator-lawsuit/uterine-sarcoma-cancer/prweb12308438.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 7, 2014 Category: Pharmaceuticals Source Type: news

Power Morcellator Petition Signatures Exceed 86,000, as Cancer Worries...
The Firm is evaluating potential legal claims on behalf of women who allegedly experienced the spread of uterine sarcoma and other cancers following uterine morcellation.(PRWeb October 31, 2014)Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/morcellator-cancer/prweb12294125.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 1, 2014 Category: Pharmaceuticals Source Type: news

As Power Morcellator Controversy Mounts, Bernstein Liebhard LLP Notes...
The Firm is evaluating potential morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine sarcomas and other cancers due to the use of a power morcellator in...(PRWeb October 29, 2014)Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/morcellator-cancer/prweb12287134.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 30, 2014 Category: Pharmaceuticals Source Type: news

Morcellator Lawsuit Alleges Gyrus Power Morcellator Promoted Growth of...
The Firm is evaluating power morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine sarcoma and other cancers due to uterine morcellation.(PRWeb October 16, 2014)Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/morcellator-cancer/prweb12255024.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 17, 2014 Category: Pharmaceuticals Source Type: news

Power Morcellator Recall: FDA Not Prepared to Issue Morcellator Recall...
The Firm is evaluating potential morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine sarcoma and other cancers due to the use of power morcellators in laparoscopic...(PRWeb October 15, 2014)Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/morcellator-cancer/prweb12251649.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 16, 2014 Category: Pharmaceuticals Source Type: news

Power Morcellator News: Potential Cancer Risk Prompts Third U.S....
The Firm is evaluating legal claims on behalf of women who allegedly experienced the spread of uterine sarcoma and other cancers due to uterine morcellation.(PRWeb October 13, 2014)Read the full story at http://www.prweb.com/releases/power-morcellator-lawsuit/uterine-sarcoma-cancer/prweb12244240.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 13, 2014 Category: Pharmaceuticals Source Type: news

Petition to Ban Power Morcellators in Uterine Surgery Surpasses 85,000...
The Firm is evaluating potential legal claims on behalf of women who allegedly experienced the spread of uterine sarcoma and other gynecological cancers due to a power morcellator.(PRWeb October 10, 2014)Read the full story at http://www.prweb.com/releases/power-morcellator-lawsuit/morcellator-cancer/prweb12240715.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 10, 2014 Category: Pharmaceuticals Source Type: news

Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes...
The Firm is evaluating power morcellator lawsuits on behalf of women who allegedly experienced the spread and upstaging of uterine sarcomas and other cancers due to uterine morcellation.(PRWeb September 25, 2014)Read the full story at http://www.prweb.com/releases/power-morcellator-lawsuit/morcellator-cancer/prweb12200445.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 25, 2014 Category: Pharmaceuticals Source Type: news

Power Morcellator News: Bernstein Liebhard LLP Notes New Report...
The Firm is investigating potential legal claims on behalf of women who allegedly experienced the spread of uterine sarcomas and other cancers due to uterine morcellation.(PRWeb September 22, 2014)Read the full story at http://www.prweb.com/releases/power-morcellator-lawsuit/morcellator-cancer/prweb12188923.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 23, 2014 Category: Pharmaceuticals Source Type: news

Minimally Invasive Uterine and Fibroid Morcellation Warnings
Sourced from The Hysterectomy Association: Hysterectomy Association - Hysterectomy Association - hysterectomy, menopause and hormone replacement therapy (hrt) information and support for women. In recent months there have been a number of warnings issued about uterine polyp and fibroid morcellation during laparascopic hysterectomy or myomectomy, most notably by the FDA in the United States. It’s come about because in a small number of cases the fibroids being removed were shown to be malignant after the surgery, something that was not known prior to the operation. In a few of these cases women went on to develop leio...
Source: The Hysterectomy Association - September 22, 2014 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Alternatives to Hysterectomy laparascopic hysterectomy morcellation myomectomy Source Type: news

As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes...
The Firm is evaluating legal claims on behalf of women who experienced the spread of uterine sarcoma and other cancers, allegedly due to uterine morcellation.(PRWeb September 20, 2014)Read the full story at http://www.prweb.com/releases/power-morcellator-lawsuit/uterine-sarcoma-cancer/prweb12185347.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 20, 2014 Category: Pharmaceuticals Source Type: news

Power Morcellator Petition Nears 85,000 Signatures, Bernstein Liebhard...
The Firm is evaluating potential morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine sarcoma and other cancers due to the use of power morcellators in laparoscopic...(PRWeb September 17, 2014)Read the full story at http://www.prweb.com/releases/power-morcellator-lawsuit/morcellator-cancer/prweb12178118.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 18, 2014 Category: Pharmaceuticals Source Type: news

Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of...
The Firm is evaluating morcellator lawsuits on behalf of women who experienced the spread of uterine sarcoma, leiomyosarcoma and other uterine cancers, allegedly due to uterine morcellation.(PRWeb August 27, 2014)Read the full story at http://www.prweb.com/releases/power-morcellator-lawsuit/uterine-sarcoma-cancer/prweb12125752.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 28, 2014 Category: Pharmaceuticals Source Type: news

Power Morcellator News: Bernstein Liebhard LLP Notes Senators’ Letter...
The Firm is evaluating potential power morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine sarcomas and other cancers due to uterine morcellation.(PRWeb August 20, 2014)Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/morcellator-recall/prweb12108875.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 21, 2014 Category: Pharmaceuticals Source Type: news

Petition to Ban Power Morcellator Surgery Now Has 62,800 Supporters,...
The Firm is evaluating power morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine sarcoma and other gynecological cancers after undergoing a procedure aided by the...(PRWeb August 15, 2014)Read the full story at http://www.prweb.com/releases/power-morcellator-lawsuit/uterine-sarcoma/prweb12099253.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 16, 2014 Category: Pharmaceuticals Source Type: news

Power Morcellator News: Bernstein Liebhard LLP Comments on Recent ABC...
The Firm is seeking to hear from women who allegedly experienced the spread of uterine sarcoma and other gynecological cancers due to uterine morcellation.(PRWeb August 11, 2014)Read the full story at http://www.prweb.com/releases/power-morcellator-lawsuit/uterine-sarcoma-cancer/prweb12085933.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 11, 2014 Category: Pharmaceuticals Source Type: news

Power Morcellator Update: Bernstein Liebhard LLP Notes Insurer’s...
The Firm is evaluating morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine sarcoma and other cancers due to uterine morcellation.(PRWeb August 04, 2014)Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/uterine-sarcoma-cancer/prweb12069947.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 5, 2014 Category: Pharmaceuticals Source Type: news

Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to...
The Firm is investigating potential morcellator lawsuits on behalf of women who allegedly experienced the upstaging of uterine sarcoma and other cancers due to uterine morcellation.(PRWeb August 01, 2014)Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/uterine-sarcoma/prweb12066613.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 2, 2014 Category: Pharmaceuticals Source Type: news

Laparoscopic Power Morcellation in Hysterectomy and Myomectomy: FDA Safety Communication - Use Discouraged Due to Increased Risk in Women With Uterine Fibroids
If laparoscopic power morcellation is performed in women with unsuspected uterine sarcoma, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis. (Source: FDA MedWatch)
Source: FDA MedWatch - April 17, 2014 Category: American Health Source Type: news

FDA discourages use of laparoscopic power morcellation for removal of uterus or uterine fibroids
In a safety communication notice issued today, the U.S. Food and Drug Administration discouraged the use of laparoscopic power morcellation for the removal of the uterus (hysterectomy) or uterine fibroids (myomectomy) in women because, based on an analysis of currently available data, it poses a risk of spreading unsuspected cancerous tissue, notably uterine sarcomas, beyond the uterus. (Source: Food and Drug Administration)
Source: Food and Drug Administration - April 17, 2014 Category: American Health Source Type: news

What is endometrial cancer? What is uterine cancer?
Endometrial cancer, also known as womb cancer or uterine cancer, is a type of cancer that begins in the uterus (womb), specifically in the layer of cells that form the lining of the uterus, called the endometrium. Endometrial cancer can also be called cancer of the womb or cancer of the uterus. Nearly all uterine cancers are endometrial cancer. However, there is another much rarer type called uterine sarcoma, in which the malignancy starts in the muscles surrounding the womb. Endometrial cancer and uterine sarcoma are usually treated differently... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 13, 2013 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news